Alamar Biosciences Inc (ALMR) Gross Profit Margin starting from the third quarter 2026 to third quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Alamar Biosciences Inc   (ALMR)


Alamar Biosciences Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



ALMR Gross Profit Margin (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Revenue Change 107.55 %
Seq. Revenue Change 13.99 %
Revenue In Millions $33.55
Gross Profit Margin 61.54 %
Gross Profit Margin Total Ranking # 1477
Gross Profit In Millions $20.64
Y / Y Gross Profit Change 140.58 %
Seq. Gross Profit Change 16.51 %


Commenting Third Quarter 2026 Gross Profit Margin
Alamar Biosciences Inc Gross Profit grew by 16.51 % in Q3 sequentially to 21 millions, while Revenue increased by 13.99 %, this led to improvement in the company's Gross Profit Margin to 61.54 % a new company high.


Observing third quarter 2026 results within Laboratory Analytical Instruments industry 5 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 1477.
Learn about Gross Margin
ALMR's Gross Profit Margin third quarter 2026 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 6
Healthcare Sector # 272
Overall # 1465

Gross Profit Margin Statistics
High Average Low
61.54 % 56.7 % 48.8 %
(Sep 30 2026)   (Mar 31 2025)




Other Gross Profit Margin Profitability Ratios
ALMR's Cumulative Gross Profit Margin
Laboratory Analytical Instruments Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
ALMR's Gross Profit Margin Profitability versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for ALMR's Competitors
Gross Profit Margin Profit Margin for Alamar Biosciences Inc 's Suppliers
Gross Profit Margin Profit Margin for ALMR's Customers

You may also want to know
ALMR's Annual Growth Rates ALMR's Profitability Ratios ALMR's Asset Turnover Ratio ALMR's Dividend Growth
ALMR's Roe ALMR's Valuation Ratios ALMR's Financial Strength Ratios ALMR's Gross Profit Growth
ALMR's Roa ALMR's Inventory Turnover Ratio ALMR's Growth Rates ALMR's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2026, within Laboratory Analytical Instruments Industry Gross Profit MarginSep 30 2026 MRQ Gross ProfitSep 30 2026 MRQ Revenue
Nautilus Biotechnology Inc   89.74 %$ 0.210  Millions$ 0.234  Millions
10x Genomics Inc   74.95 %$ 112.927  Millions$ 150.667  Millions
Illumina Inc   73.52 %$ 830.000  Millions$ 1,129.000  Millions
Alamar Biosciences Inc   61.54 %$ 20.644  Millions$ 33.545  Millions
Mettler toledo International Inc   59.79 %$ 654.224  Millions$ 1,094.294  Millions
Cytek Biosciences Inc   58.63 %$ 31.206  Millions$ 53.229  Millions
Revvity Inc  57.43 %$ 418.579  Millions$ 728.899  Millions
Standard Biotools Inc   55.86 %$ 10.828  Millions$ 19.385  Millions
Harvard Bioscience Inc   55.45 %$ 12.307  Millions$ 22.196  Millions
Waters Corporation  50.25 %$ 888.000  Millions$ 1,767.000  Millions
Bio rad Laboratories Inc   50.06 %$ 328.600  Millions$ 656.400  Millions
Bruker Corporation  49.12 %$ 429.300  Millions$ 874.000  Millions
Bionano Genomics Inc   47.72 %$ 3.949  Millions$ 8.276  Millions
Seer Inc   47.20 %$ 1.879  Millions$ 3.981  Millions
Precipio inc   46.08 %$ 3.378  Millions$ 7.331  Millions
Quanterix Corporation  38.60 %$ 13.500  Millions$ 34.974  Millions
Pacific Biosciences Of California Inc   33.21 %$ 13.470  Millions$ 40.564  Millions
Avantor Inc   31.49 %$ 534.800  Millions$ 1,698.300  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.